Immunogen (IMGN) Stock Highlights

31.23 | +0%

2024-12-21 01:27:12

Immunogen Inc is a clinical-stage biotechnology company from the United States. Its focus is antibody-drug conjugate, or ADC, technology, which uses an antibody that fixes on a target (its antigen) found on tumor cells to deliver a specific cancer-killing agent. The technology is used in Kadcyla (ado-trastuzumab emtansine)--a registered trademark of Genentech, a member of the Roche Group--to kill solid tumors. Companies such as Amgen, Genentech/Roche, Lilly, Novartis, Sanofi, and Takeda have licensed limited rights to use the ADC technology in their therapies.

Statistics

Range Today

31.23 31.23

Volume Today 0

Range 1 Year

3.61 31.25

Volume 1 Year 1.61B

Range 3 Year

3.1 31.25

Volume 3 Year 3.11B

Range 10 Year

1.51 31.25

Volume 10 Year 7.02B

Highlights

Market Capitalization 8.72B (mid)

Floating Shares 247.85M

Current Price 31.23

Price To Earnings -111.57

Price To Revenue 27.1

Price To Book 14.78

Earnings Per Share -0.28

Payout Ratio 0%

Performance

Latest 0%

1 Month +5.08%

3 Months +114.93%

6 Months +119.62%

1 Year +617.93%

3 Years +197.43%

5 Years +478.33%

10 Years +98.41%

Benchmarks

Market Capitalization

20 / 368

Gross Profits

239 / 278

Total Revenue

42 / 300

Total Rank

155 / 368

Free Cashflow

305 / 352

Performance 5 years

14 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.